Nvidia just updated its stock portfolio

Nvidia (NASDAQ: NVDA) has updated its stock portfolio, revealing a public equity portfolio worth approximately $63.4 billion as of June 30, 2026, according to a Form 13F filing. The filing highlights a dramatic increase from the previous quarter’s portfolio value of about $18.4 billion, driven by gains in existing holdings and the addition of a large SpaceX (NASDAQ: SPCX) position. A breakdown of the investments indicates that Intel (NASDAQ: INTC) remains the largest position in Nvidia’s stock portfolio. The chipmaker held 214.8 million Intel shares valued at roughly $30 billion at the end of the second quarter, accounting for 44.23% of the disclosed portfolio. The stake was originally established through a $5 billion investment announced in 2025 as part of a collaboration focused on developing chips for personal computers and data centers. Compared to the previous quarter, Intel’s weighting in the portfolio declined from 51.58%, despite a significant increase in the market value of the position. Meanwhile, the biggest change in Nvidia’s investment portfolio was the addition of SpaceX. Nvidia disclosed ownership of 122.8 million SpaceX Class A shares valued at nearly $21 billion, representing 30.94% of the portfolio. The filing marks the first time the company has publicly reported the value of its SpaceX stake following the aerospace firm’s public listing. The position is linked to Nvidia’s earlier participation in funding Elon Musk’s xAI. Following SpaceX’s acquisition of xAI and its subsequent market debut, the investment became one of Nvidia’s largest assets. Outside of Intel and SpaceX, Nvidia continues to hold significant positions across the artificial intelligence and semiconductor sectors. In this segment, CoreWeave ranked as the third-largest holding with a market value of approximately $4.7 billion, representing 6.93% of the portfolio. Nebius Group (NASDAQ: NBIS) followed closely at about $4.69 billion, accounting for 6.91%. Other notable holdings included Coherent (NYSE: COHR) at roughly $3.07 billion, Nokia at $2.21 billion, and Synopsys (NASDAQ: SNPS) at $2.15 billion. Nvidia also reported a smaller position in Generate Biomedicines (NASDAQ: GENB) valued at about $14 million. The latest Nvidia 13F filing shows a highly concentrated portfolio. Intel and SpaceX alone accounted for more than 75% of the total disclosed value at the end of the quarter. While the filing provides a snapshot as of June 30, market conditions have since changed. SpaceX shares have fallen from the valuation level used in the filing, while Intel has also retreated from its quarter-end price, reducing the current value of both holdings.